A recent comparative effectiveness study analyzed hybrid capture-based sequencing vs amplicon gene sequencing for the detection of cancer-specific mutations in lymphoid tumors.

News

A model that incorporates patient-specific characteristics for those with acute myeloid leukemia (AML) may help predict mortality after treatment, according to an investigation published in JAMA Oncology (online September 7, 2017;doi:10.1001/jamaoncol.2017.2714).

Read More

By Megan Brooks

NEW YORK (Reuters Health) - Opting to forgo radiotherapy can be considered in children with Hodgkin lymphoma who achieve metabolic remission on interim positron emission tomography (PET) after doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) chemotherapy, suggest results of a small study from India.

Read More

By Rob Goodier

NEW YORK (Reuters Health) - Obese children and adolescents may suffer higher rates of treatment-related mortality after chemotherapy for acute myeloid leukemia (AML), a new secondary analysis of a drug trial suggests.

Read More

Novel oral targeted therapies for the treatment of chronic lymphocytic leukemia (CLL) could raise treatment costs by 600%, according to an analysis in the Journal of Clinical Oncology.

Read More

Subscribe to Blood Cancer